KO
38
-3
MSI
72
-3
HCP
56
-8
JBHT
56
-3
FE
44
5
ORLY
60
-5
USB
50
-3
EL
15
-3
GM
74
5
ORCL
63
-4
MCHP
34
-2
MTCH
20
-8
CRM
60
-7
DG
8
-2
EQR
54
3
MO
60
-2
WEC
53
5
C
62
4
TGT
45
-4
EXPD
43
-4
KO
38
-3
MSI
72
-3
HCP
56
-8
JBHT
56
-3
FE
44
5
ORLY
60
-5
USB
50
-3
EL
15
-3
GM
74
5
ORCL
63
-4
MCHP
34
-2
MTCH
20
-8
CRM
60
-7
DG
8
-2
EQR
54
3
MO
60
-2
WEC
53
5
C
62
4
TGT
45
-4
EXPD
43
-4
Financhill
Back

Unity Software Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
40

U
Unity Software

Last Price:
17.34
Seasonality Move:
3.04%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
40
Unity Software (U) is a Sell

Is Unity Software a Buy, Sell or Hold?

  • The current Unity Software [U] share price is $17.34. The Score for U is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • U is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

U Stock Price Chart

What is Unity Software's stock price today?

  • The Unity Software share price today is $17.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and U is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

U Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 32.21 Sell
Chaikin Money Flow: -16032072 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.5 - 21.84) Sell
Bollinger Bands (100): (15.91 - 20.91) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

U Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.89 Sell
20-day SMA: 20.37 Sell
50-day SMA: 20.57 Sell
200-day SMA: 21.62 Sell
8-day EMA: 19.34 Sell
20-day EMA: 20.14 Sell
50-day EMA: 20.04 Sell
200-day EMA: 22.14 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Unity Software Earnings Growth & U Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.11 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Unity Software Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):